-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

503. Clonal Hematopoiesis: Aging and Inflammation: Poster III

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
AML, Coronaviruses, HSCs, SARS-CoV-2/COVID-19, Diseases, Elderly, red blood cells, Biological Processes, white blood cells, immune cells, Technology and Procedures, Cell Lineage, epigenetics, Study Population, Clinically relevant, genomics, Myeloid Malignancies, hematopoiesis, flow cytometry, NGS, RNA sequencing, senescence
Monday, December 7, 2020: 7:00 AM-3:30 PM

Tingting Hong1*, Shengli Li, PHD2*, Shaohai Fang, MS3*, Anna Guzman4*, Wei Han, MS3*, Yubin Zhou, PhD5*, Leng Han, PhD6*, Margaret Goodell, PhD7 and Yun Huang, PhD8,9

1Institute of Biosciences and Technology, Texas A&M health science center, HOUSTON, TX
2Department of Biochemistry and Molecular Biology, McGovern Medical School at UTHealth, The University of Texas Health Science Center at Houston, Houston, TX
3Center for Epigenetics and Disease Prevention, Texas A&M University, Institute of Biosciences and Technology, Houston, TX
4Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX
5Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M University, Houston, TX
6Department of Biochemistry and Molecular Biology, University of Texas Health Science Center at Houston, Houston, TX
7Molecular and Cellular Biology Department, Baylor College of Medicine, Houston, TX
8Institute of Biosciences and Technology, Texas A&M University, College of Medicine, Houston
9Center for Epigenetics & Disease Prevention, Institute of Biosciences and Technology, Texas A&M University, Houston, TX

Luise Hartmann1,2,3,4*, Judith Hecker, MD5*, Jennifer Beauvarlet5*, Mark Van Der Garde, MSc, PhD2,4,5*, Michele Kyncl, MSc5*, Maja Rothenberg-Thurley, PhD3*, Luise Fischer, PhD6,7*, Susann Winter, PhD6,7*, Bianka Ksienzyk3*, Frank Ziemann, MD1,2,4*, Martina Rauner, PhD8*, Elena Tsourdi, MD8*, Jörg Lützner, MD9*, Andreas Roth, MD10*, Karsten Spiekermann, MD1,2,3,4, Lorenz C Hofbauer, MD6,8*, Uwe Platzbecker, MD2,6,11, Katharina S. Götze2,4,5 and Klaus H. Metzeler, MD1,2,3,4

1Experimental Leukemia and Lymphoma Research (ELLF), University Hospital, LMU Munich, Munich, Germany
2German Cancer Research Center (DKFZ), Heidelberg, Germany
3Laboratory for Leukemia Diagnostics, Department of Hematology and Oncology, University Hospital, LMU Munich, Munich, Germany
4CHOICE consortium, German Cancer Consortium (DKTK), Munich, Germany
5Department of Medicine III, Technical University of Munich, Munich, Germany
6CHOICE consortium, German Cancer Consortium (DKTK), Dresden, Germany
7Medical Clinic I, Technical University of Dresden, Dresden, Germany
8Center for Healthy Aging, Technical University of Dresden, Dresden, Germany
9Department of Orthopedic Surgery, Technical University of Dresden, Dresden, Germany
10Department of Orthopedic Surgery, University Hospital Leipzig, Leipzig, Germany
11Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany

Kimberly Skead1,2*, Armande Ang Houle1,2*, Sagi Abelson, PhD1,2*, Marie-Julie Fave, PhD2*, Boxi Lin3*, David Soave, PhD2,4*, Stephen Wright, PhD5*, John E. Dick, PhD, FRS1,2,6, Quaid Morris, PhD1,2,7* and Phillip Awadalla, PhD1,2*

1Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada
2Ontario Institute for Cancer Research, Toronto, ON, Canada
3Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada
4Department of Mathematics, Wilfrid Laurier Univesity, Waterloo, ON, Canada
5Department of Ecology and Evolutionary Biology, University of Toronto, Toronto, ON, Canada
6Princess Margaret Cancer Centre, University Health Network (UHN), Toronto, ON, Canada
7Computational & Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY

Kelly L. Bolton, MD, PhD1, Michael Foote, MD2*, Justin Jee3*, Anton Safonov, MD4, Ryan Ptashkin, MS5*, Sean Devlin, PhD6*, Erika Gedvilaite5*, Teng Gao7*, Elli Papaemmanuil, PhD8,9, Melissa S. Pessin, MD, PhD10*, Mini Kamboj3*, Joseph Vijai, PhD4, Kenneth Offit, MD11*, Phillip Awadalla, PhD12*, Pradeep Nataranjan13*, Michael F. Berger, PhD5,14*, Larry Norton, MD15*, Ross L. Levine, MD3 and Ahmet Zehir, PhD5*

1Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, FAIRFEILD, CT
2Memorial Sloan Kettering Cancer Center, New York
3Memorial Sloan Kettering Cancer Center, New York, NY
4Memorial Sloan Kettering, New York, NY
5Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
6Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
7Center for Computational Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
8Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
95Computational Oncology Service, Department of Epidemiology & Biostatistics, Center for Computational Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
10Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
11Memorial Sloan-Kettering Cancer Ctr., New York, NY
12Ontario Institute for Cancer Research, Ontario, Canada
13Harvard Medical School, Cambridge, MA
14Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY
15Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY

*signifies non-member of ASH